Invitae Corp. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
24,838.00
47,492.00
89,782.00
100,256.00
123,380.00
129,355
Depreciation, Depletion & Amortization
928.00
2,315.00
5,321.00
6,553.00
9,181.00
13,540
Other Funds
-
1,451.00
-
-
-
27,347
Funds from Operations
23,650.00
44,169.00
80,329.00
81,663.00
94,620.00
88,468
Changes in Working Capital
620.00
1,729.00
326.00
5,346.00
3,361.00
3,752
Net Operating Cash Flow
23,030.00
42,440.00
80,655.00
76,317.00
97,981.00
92,220
Capital Expenditures
4,520.00
6,686.00
6,464.00
11,625.00
6,675.00
Sale of Fixed Assets & Businesses
-
-
-
-
2,821.00
Purchase/Sale of Investments
-
-
54,427.00
27,820.00
33,099.00
Net Investing Cash Flow
4,580.00
6,716.00
60,891.00
16,195.00
36,953.00
Issuance/Reduction of Debt, Net
1,007.00
1,376.00
5,030.00
3,473.00
6,252.00
Net Financing Cash Flow
48,879.00
113,113.00
112,438.00
53,709.00
80,871.00
Net Change in Cash
21,269.00
63,957.00
29,108.00
6,413.00
54,063.00
Free Cash Flow
27,550.00
49,126.00
87,119.00
87,942.00
104,656.00
Change in Capital Stock
49,886.00
115,940.00
107,408.00
50,236.00
74,619.00
Other Uses
60.00
30.00
-
-
-

About Invitae

View Profile
Address
1400 16th Street
San Francisco California 94103
United States
Employees -
Website http://www.invitae.com
Updated 07/08/2019
Invitae Corp. engages in the provision of genetic information into mainstream medical practice. It includes comprehensive panels for hereditary conditions in cancer, cardiology, neurology, pediatric, and rare diseases. The company was founded by Randal W.